US acquires 200 mn more COVID vaccine doses | Daily News

US acquires 200 mn more COVID vaccine doses

US President Joe Biden (L) listens to Dr. Kizzmekia S. Corbett (R) when he toured the Viral Pathogenesis Laboratory at the National Institutes of Health (NIH) in Bethesda, Maryland on Thursday.  White House Chief Medical Adviser on COVID-19 Dr. Anthony Fauci is at Centre.- AFP

US President Joe Biden (L) listens to Dr. Kizzmekia S. Corbett (R) when he toured the Viral Pathogenesis Laboratory at the National Institutes of Health (NIH) in Bethesda, Maryland on Thursday.  White House Chief Medical Adviser on COVID-19 Dr. Anthony Fauci is at Centre.- AFP

US: US President Joe Biden said Thursday the US had signed deals to acquire 200 million more Covid-19 vaccine doses as officials look to immunize the vast majority of the population by July.

The deals with Pfizer and Moderna, which the administration had announced it was seeking last month, increase the country's total vaccine supply by fifty percent, to 600 million doses.

"Just this afternoon, we signed ... final contracts for 100 million more Moderna and 100 million more Pfizer vaccines," Biden said after touring the National Institutes of Health near Washington.

"We're now on track to have enough supply for 300 million Americans by the end of July," he added. Both vaccines currently authorized for emergency use in the US require two shots.

The US immunization campaign got off to a shaky start in December but has since improved: 46.4 million shots have now reached arms, and at least 34.7 million people have received one or more doses, roughly 10 percent of the population.

The vaccine drive entered a new phase Thursday as 6,500 pharmacies began scheduling shots, but a wave of optimism brought about by falling cases could soon be tested by dangerous variants.

Anthony Fauci, the President's Chief Advisor on the pandemic, told NBC that by April, vaccines would start being available to anyone who wanted them. While the shots are currently only available to adults, officials have voiced hope that ongoing studies would allow them to be approved for children in the coming months.

Since peaking on January 8 following the holiday season, the US outbreak has been in steep decline, with an average of just over 100,000 daily cases -- down from more than 300,000.

Between the number of people already vaccinated and the number of people who've already been infected, it's thought that around 40 percent of the population might have some immunity, which is also contributing to the slowdown in new cases.

The highly-transmissible B.1.1.7 variant that was first identified in Britain is also rapidly spreading in the US and is set to become the dominant strain by March, according to multiple studies.

This has the potential to reverse current progress, just as it did for example in Ireland, which had gotten its outbreak under control by late 2020, but was hit by a B.1.1.7 driven exponential wave in January and still recovering.

- AFP